Abbott bumps up profit forecast on strong medical device sales

Abbott Laboratories (ABT.N) slightly lifted its annual profit forecast on Wednesday, after beating Wall Street estimates for quarterly earnings on strong demand for its continuous glucose monitors (CGMs) and other medical devices.